ReviewFrontiers in oncology2014

Ras/Raf/MEK/ERK Pathway Activation in Childhood Acute Lymphoblastic Leukemia and Its Therapeutic Targeting.

Thomas Knight et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.